News - Mill Creek Life Sciences

News

Stay up to date on all of the latest News, Events, and Press Releases at Mill Creek Life Sciences.

Articles and Press Releases

December 10, 2019

Mayo Clinic, W. L. Gore & Associates announce Avobis Bio, a joint venture for new regenerative therapies

Congratulations to our founder, Dr. Allan Dietz, on the exciting news! Our platelet lysate, PLTMax®, was used to manufacture the cells for the clinical trial, as well as other studies at Mayo. Platelet lysate is a key component in growing these stem cells.

November 27, 2019

Stem cells a step toward improving motor, sensory function after spinal cord injury

What an amazing story! Congratulations to Chris Barr and his family, as well as the Mayo Clinic team on their recent stem cell work in spinal cord injury! Our founder, Dr. Allan Dietz, directs the Mayo IMPACT lab which manufactured the stem cells in this trial.

Mill Creek’s platelet lysate, PLTMax®, was used to manufacture the cells for this trial, as well as other studies at Mayo. Platelet lysate is an important component for the growth of these stem cells.

June 18, 2019

Mill Creek Life Sciences Receives Grant from Regenerative Medicine Minnesota for Development of Dendritic Cell Vaccine

Mill Creek Life Sciences, LLC (Mill Creek), a Rochester, MN based start-up that supports the development and application of cellular and biological therapeutics, has received a one-year $100,000 grant from Regenerative Medicine Minnesota (RMM) titled: "Development of Technology for the Large-scale Production of a Novel Dendritic Cell Vaccine for the Treatment of Glioblastoma."

November 8, 2018

Mill Creek Life Sciences Announces Certification to ISO 9001:2015

Mill Creek Life Sciences, LLC (Mill Creek), a Rochester, MN based start-up that provides tools to support the development and application of cellular and biological therapeutics, is pleased to announce they have been certified under ISO 9001:2015 by DNV GL, effective September 10, 2018.

May 30, 2018

2018 MN Cup Semifinalists!

Mill Creek Life Sciences named a semifinalist in the 2018 MN Cup entrepreneurial competition.

August 22, 2017

Efficient Large-Scale Expansion of MSCs for Translational Medicine and Research Use

Featured article from ISSCR 2017 on MSC NutriStem® Basal Medium (Biological Industries USA) and PLTMax® Human Platelet Lysate (Mill Creek Life Sciences)

Stay Tuned for Upcoming Events

2026 Events

AACR Annual Meeting

April 17 - 22, 2026

San Diego, California

ISCT Annual Meeting

May 6 - 9, 2026

Dublin, Ireland

ASGCT Annual Meeting

May 11 - 15, 2026

Boston, Massachusetts

ISSCR Annual Meeting

July 8 - 11, 2026

Montreal, Canada

MicrosoftTeams-image (21)

For media inquiries, contact info@millcreekls.com.

REQUEST SAMPLES